Novo Nordisk for Osteoarthritis - Search News

News

Novo Nordisk opens weight loss drug Wegovy to telehealth

Novo Nordisk strikes telehealth deals for obesity drug, following Eli Lilly

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies

CNBC on MSN · 2d

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.

The Hill on MSN · 1d

Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would

Eli Lilly shares fall as competitor Novo notches coverage win for obesity drug

Eli Lilly shares dropped Thursday as Novo Nordisk notched a coverage win for its obesity drug, a sign of the competition in ...

Fierce Pharma9d

Facing added pressure from Eli Lilly, Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

1don MSN

Why Novo Nordisk Stock Is Soaring Today

Shares of Novo Nordisk ( NVO 2.06%) are up on Tuesday. The company's stock gained 3.9% as of 2:40 p.m. ET today and was up as ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results